Daivobet Dosage/Direction for Use

Ointment: Calcipotriol hydrate and betamethasone dipropionate (Daivobet) should be applied to the affected area once daily. There is experience with repeated courses of Calcipotriol hydrate and betamethasone dipropionate (Daivobet) up to 52 weeks. If it is necessary to continue or restart treatment after 4 weeks, treatment should be continued after medical review and under regular medical supervision.
When using calcipotriol containing medicinal products, the maximum daily dose should not exceed 15 g and the maximum weekly dose should not exceed 100 g.
The body surface area treated with calcipotriol containing medicinal products should not exceed 30%.
Special populations: Renal and hepatic impairment: The safety and efficacy of Calcipotriol hydrate and betamethasone dipropionate (Daivobet) in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated.
Paediatric population: The safety and efficacy of Calcipotriol hydrate and betamethasone dipropionate (Daivobet) in children below 18 years have not been established.
Currently available data in children aged 12 to 17 years are described in Adverse Reactions and Pharmacology: Pharmacodynamics under Actions but no recommendation on a posology can be made.
Method of administration: Calcipotriol hydrate and betamethasone dipropionate (Daivobet) should be applied to the affected area. In order to achieve optimal effect, it is not recommended to take a shower or bath immediately after application of Calcipotriol hydrate and betamethasone dipropionate (Daivobet).
Gel: Posology: Daivobet Gel should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for "non-scalp" areas. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision. When using calcipotriol containing medicinal products, the maximum daily dose should not exceed 15 g and the maximum weekly dose should not exceed 100 g. The body surface area treated with calcipotriol containing medicinal products should not exceed 30%.
If used on the scalp: All the affected scalp areas may be treated with Daivobet Gel. Usually an amount between 1 g and 4 g per day is sufficient for treatment of the scalp (4 g corresponds to one teaspoon).
Special populations: Renal and hepatic impairment: The safety and efficacy of Daivobet Gel in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated.
Paediatric population: The safety and efficacy of Daivobet Gel in children below 18 years have not been established. Currently available data in children aged 12 to 17 years are described in Adverse Reactions and Pharmacology: Pharmacodynamics under Actions, but no recommendation on a posology can be made.
Method of administration: Daivobet Gel should not be applied directly to the face or eyes. In order to achieve optimal effect, it is not recommended to take a shower or bath, or to wash the hair in case of scalp application, immediately after application of Daivobet Gel. Daivobet Gel should remain on the skin during the night or during the day.
When using the bottle: Shake the bottle before use and apply Daivobet Gel to the affected area. The hands should be washed after use.